Aline Mizusaki Imoto1, Leila Bernarda Gottems2, Ana Lúcia Salomon3, Helbert Eustáquio Cardoso E Silva2, Império Lombardi Júnior4, Maria Stella Peccin4, Fábio Ferreira Amorim5,6, Levy Aniceto Santana2. 1. Evidences-Based Health Lab, Professional and Academic Master Program, Escola Superior em Ciências da Saúde, Brasília, DF, Brazil. alinem.imoto@gmail.com. 2. Evidences-Based Health Lab, Professional and Academic Master Program, Escola Superior em Ciências da Saúde, Brasília, DF, Brazil. 3. Professional and Academic Master Program, Escola Superior em Ciências da Saúde, Brasília, DF, Brazil. 4. Human Movement Sciences Department, Interdisciplinary Post-Graduation Program in Health Sciences, Universidade Federal de São Paulo (UNIFESP), Santos, SP, Brazil. 5. Medicine Graduation Course, Escola Superior em Ciências da Saúde, Brasília, DF, Brazil. 6. Family Health Master Program (ProfSaúde), Escola Superior em Ciências da Saúde, Brasília, DF, Brazil.
Abstract
BACKGROUND: Diet plays a critical role in Systemic Lupus Erythematosus (SLE) patients, impacting on the microbiota composition and, consequently, on the immune response. The objective was to analyze and verify the diet effect on SLE patients. METHODS: This is a systematic review performed at the Evidences-based Health Lab, Escola Superior em Ciências da Saúde, Brasília (DF), Brazil. In March, 2021, five databases, and grey literature, through JSTOR, Open Grey, and Google Scholar were searched. Randomized Clinical Trials in which SLE patients with calorie restricted, low glycemic index or other diet involving the joint adequacy of these aspects, compared with placebo or different types of diet, were included. RESULTS: It was identified in the databases 758 articles; 132 were duplicated; 616 references were screened, and 604 were excluded. After reading the title and abstract, 12 articles were included for full-text reading. After the full-text reading, three studies were included for quantitative analysis. The diet improved the quality of life at 6 (MD 16.30; 5.91;26.69) and 12 weeks (MD 14.60; 0.88;28.32). The GRADE was used to evaluate the quality of evidence. CONCLUSION: There is low evidence that the diet has a positive impact on the quality of life of SLE patients. Trial registration PROSPERO-CRD4202012208.
BACKGROUND: Diet plays a critical role in Systemic Lupus Erythematosus (SLE) patients, impacting on the microbiota composition and, consequently, on the immune response. The objective was to analyze and verify the diet effect on SLE patients. METHODS: This is a systematic review performed at the Evidences-based Health Lab, Escola Superior em Ciências da Saúde, Brasília (DF), Brazil. In March, 2021, five databases, and grey literature, through JSTOR, Open Grey, and Google Scholar were searched. Randomized Clinical Trials in which SLE patients with calorie restricted, low glycemic index or other diet involving the joint adequacy of these aspects, compared with placebo or different types of diet, were included. RESULTS: It was identified in the databases 758 articles; 132 were duplicated; 616 references were screened, and 604 were excluded. After reading the title and abstract, 12 articles were included for full-text reading. After the full-text reading, three studies were included for quantitative analysis. The diet improved the quality of life at 6 (MD 16.30; 5.91;26.69) and 12 weeks (MD 14.60; 0.88;28.32). The GRADE was used to evaluate the quality of evidence. CONCLUSION: There is low evidence that the diet has a positive impact on the quality of life of SLE patients. Trial registration PROSPERO-CRD4202012208.
Authors: S G L da Silva; M T Terreri; T T O Abad; D Machado; F L A Fonseca; S Hix; F I Suano-Souza; R O S Sarni; C A Len Journal: Lupus Date: 2018-01-10 Impact factor: 2.911
Authors: Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder Journal: Arthritis Rheum Date: 2012-08
Authors: Benjamin Chaigne; Carlo Chizzolini; Thomas Perneger; Marten Trendelenburg; Uyen Huynh-Do; Eric Dayer; Thomas Stoll; Johannes von Kempis; Camillo Ribi Journal: BMC Immunol Date: 2017-03-28 Impact factor: 3.615